Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Apr 1.

Published in final edited form as: Clin Nucl Med. 2012 Apr;37(4):344–350. doi: 10.1097/RLU.0b013e31824437b3

Comparison of Magnetic Resonance Imaging and Molecular Breast Imaging Before and After Neoadjuvant Therapy. The pre-NT imaging shows a 4.5-cm mass on (A) magnetic resonance imaging (MRI) and (B) molecular breast imaging (MBI), whereas the post-NT imaging (C) by MRI shows a persistent 2.1-cm lesion with decreased enhancement, and (D) by MBI is negative (tumor-to-background ratio, <1.1).

Comparison of Magnetic Resonance Imaging and Molecular Breast Imaging Before and After Neoadjuvant Therapy. The pre-NT imaging shows a 4.5-cm mass on (A) magnetic resonance imaging (MRI) and (B) molecular breast imaging (MBI), whereas the post-NT imaging (C) by MRI shows a persistent 2.1-cm lesion with decreased enhancement, and (D) by MBI is negative (tumor-to-background ratio, <1.1).